<code id='1BADDCD7D8'></code><style id='1BADDCD7D8'></style>
    • <acronym id='1BADDCD7D8'></acronym>
      <center id='1BADDCD7D8'><center id='1BADDCD7D8'><tfoot id='1BADDCD7D8'></tfoot></center><abbr id='1BADDCD7D8'><dir id='1BADDCD7D8'><tfoot id='1BADDCD7D8'></tfoot><noframes id='1BADDCD7D8'>

    • <optgroup id='1BADDCD7D8'><strike id='1BADDCD7D8'><sup id='1BADDCD7D8'></sup></strike><code id='1BADDCD7D8'></code></optgroup>
        1. <b id='1BADDCD7D8'><label id='1BADDCD7D8'><select id='1BADDCD7D8'><dt id='1BADDCD7D8'><span id='1BADDCD7D8'></span></dt></select></label></b><u id='1BADDCD7D8'></u>
          <i id='1BADDCD7D8'><strike id='1BADDCD7D8'><tt id='1BADDCD7D8'><pre id='1BADDCD7D8'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:4927
          Adobe

          UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

          “Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

          advertisement

          Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

          MollyFerguson/STATThisweek,apreviewoftheTUDCAstudyinALSandthoughtsonhowitmightimpactAmylyxPharmaceut

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          After gene therapy, two congenitally deaf children hear for the first time

          AdobeTwocongenitallydeafchildrencanhearforthefirsttimeafterbeingtreatedwithgenetherapy,accordingtoda